Clinical Trials

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT06075849 2024-02-23

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06173011 2024-01-23

A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults

168 enrolled

Neoplasms

NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

189 enrolled

Neoplasms, Neoplasms by Histologic Type

NCT06147362 2023-11-27

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

50 enrolled

Neoplasms

NCT04343859 2023-11-09

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

96 enrolled

Neoplasms

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05259319 2023-10-17

IMMUNOs-SBRT

GenitourinaryHead & NeckThoracic

92 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT06080984 2023-10-12

The Application of Novel Oncolytic Virus in Late Stage Solid Tumors

24 enrolled

Neoplasms

NCT06065592 2023-10-06

CAT_PB

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT05985083 2023-10-04

A Study Of IMM47 In Subjects With Advanced Solid Tumors

48 enrolled

Neoplasms

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

60 enrolled

Lymphoid

Lymphoma, Neoplasms, Neoplasms, Experimental

NCT05767684 2023-08-25

Neoantigen Derived DCs as Cancer Treatment

12 enrolled

Neoplasms

NCT05235438 2023-05-24

Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor

16 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms

NCT05539157 2023-04-04

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

1 enrolled

Dermatologic

Neoplasms, Skin Neoplasms

NCT04787003 2023-03-23

Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors

50 enrolled

Neoplasms

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

29 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT04900519 2023-01-17

Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

100 enrolled

Neoplasms

NCT05650385 2022-12-14

A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors

68 enrolled

Neoplasms

NCT03142204 2022-12-05

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

Neoplasms

NCT05042466 2022-11-16

NWTTPS

Depression, Neoplasms, Stress Disorders, Post-Traumatic, Wounds and Injuries, Trauma, Nervous System

NCT03491631 2022-11-04

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

23 enrolled

Neoplasm Metastasis, Neoplasms

NCT05150457 2022-09-27

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

48 enrolled

Neoplasm Metastasis, Neoplasms, Recurrence

NCT05549557 2022-09-22

IMM40H Phase I Dose Escalation and Expansion

16 enrolled

Neoplasms

NCT03634982 2022-09-01

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

133 enrolled

Urinary Bladder Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Noonan Syndrome, Ovarian Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Skin Neoplasms, Thoracic Neoplasms, Uterine Neoplasms, Neoplasms, Squamous Cell

NCT03934827 2022-08-11

MICROBIOME